Algazi, Alain P. http://orcid.org/0000-0001-6576-4659
Othus, Megan http://orcid.org/0000-0001-8176-6371
Daud, Adil I. http://orcid.org/0000-0002-6617-8421
Lo, Roger S.
Mehnert, Janice M.
Truong, Thach-Giao
Conry, Robert
Kendra, Kari
Doolittle, Gary C.
Clark, Joseph I.
Messino, Michael J.
Moore, Dennis F. Jr
Lao, Christopher
Faller, Bryan A.
Govindarajan, Rangaswamy
Harker-Murray, Amy
Dreisbach, Luke
Moon, James
Grossmann, Kenneth F.
Ribas, Antoni http://orcid.org/0000-0003-3669-8458
Funding for this research was provided by:
NIH/NCI grants to SWOG supporting the research presented here are listed and apply to all co-authors.
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01 CA244118, R35 CA197633, P01 CA244118)
In addition to SWOG grants listed above.
In addition to SWOG grants listed under the corresponding author that apply to all coauthors.
Article History
Received: 7 May 2020
Accepted: 13 August 2020
First Online: 5 October 2020
Competing interests
: A.P.A.—research support, advisory board member, consultant, shareholder and honorarium recipient, OncoSec. Advisory board member and stock shareholder for Valitor Biosciences. Advisory board member and honorarium recipient for Regeneron and Array. Research support from Acerta, Amgen, AstraZeneca, BMS, Dynavax, Genentech, Idera, Incyte, ISA, LOXO, Merck, Novartis, Sensei and Tessa. M.O.—consultant for Merck, Daiichi Sanko and Glycomimetics. DSMC member for Celgene and Glycomimetics. A.I.D.—research funding from GSK, Novartis, Merck, BMS, Incyte and Checkmate. Consultant for Pfizer, Roche, Incyte, BioNTech, Merck and BMS. J.M.M.—consultant and honorarium recipient for Array. Grant support/contractor for Merck. Research support from Sanofi, Polynoma, Amgen, AstraZeneca, Incyte, Macro Genics and BMS. Research support and advisory board member for EMD Serono. K.K.—research support from Merck, BMS, Immunocore, Medpace and Novartis. G.C.D.—speakers bureau for Novartis, BMS and Merck. J.I.C.—speakers bureau for BMS and Merck. Research support to institution BMS, Aveo, Argos Therapeutics, Genentech/Roche and Nektar. Immediate family member is employed full time by BMS. K.F.G.—consulting for BMS, Genentech, Castle Biosciences, Novartis, Array and Pfizer. R.S.L.—research support from Array, Merck, Novartis, OncoSec and BMS. Honorarium recipient from Amgen. A.R.—consultant/independent contractor and honorarium recipient: Amgen, Chugai, Merck, Novartis and Sanofi. Advisor/board member and honorarium recipient: Arcus, Bioncotech, Compugen, CytomX, ImaginAb, Isoplexis, Merus, Rgenix, Lutris, PACT Pharma and Tango Therapeutics. Stock shareholder (self-managed): Arcus, Compugen, CytomX and Merus. Research support from Agilent and BMS.